We aimed at finding a simple rule to determine the shortest duration of dual therapy for all HCV genotypes , obtained by multiplying time to Initial Viral Response , IVR ( first undetectable HCV-RNA ) by @ ( Tailored Therapy-@ , or TT@ ) .